Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media
More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
03/2005
03/31/2005WO2005028620A2 Histone modifications as binary switches controlling gene expression
03/31/2005WO2005028619A2 Nanoliter-scale synthesis of arrayed biomaterials and screening thereof
03/31/2005WO2005028618A2 Immunogenic compositions for streptococcus agalactiae
03/31/2005WO2005028617A2 Antisense inhibition of laminin-8 expression to inhibit human gliomas
03/31/2005WO2005028616A2 Morphogen compositions and methods of use thereof to treat heart disorders
03/31/2005WO2005028615A2 Methods and compositions for detecting promoter activity and expressing fusion proteins
03/31/2005WO2005012495A3 Methods for expression and purification of immunotoxins
03/31/2005WO2005007822A3 Method for assaying protein-protein interaction
03/31/2005WO2004106487A3 Improvements in grass endophytes
03/31/2005WO2004094616A9 Silencing transcription by methylation
03/31/2005WO2004094605A3 Methods and compositions for inhibiting stat signaling pathways
03/31/2005WO2004092351A3 Production of a transgenic avian by cytoplasmic injection
03/31/2005WO2004087876A3 Use of red blood cells to facilitate cell activation
03/31/2005WO2004081189A3 Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and organisms
03/31/2005WO2004081181A3 Method for determining susceptibility of tumor to treatment with anti-neoplastic agent
03/31/2005WO2004072234A3 Protection of nucleosides
03/31/2005WO2004048522A3 Modulation of huntingtin interacting protein 2 expression
03/31/2005WO2003054143A3 Genes and polymorphisms on chromosome 10 associated with alzheimer's disease and other neurodegenerative diseases
03/31/2005WO2003044178A8 Hybrid oligonucleotide primers for amplification of dna and uses thereof
03/31/2005US20050070693 Chimeric monoclonal antibody specific to leukocyte receptor for use as tool in treatment and prevention of cell proliferative, autoimmune, prion, liver and inflammatory disorders; immunotherapy
03/31/2005US20050070689 Nucleotide sequences coding transmembrane activator and CAML interactor (TACI) protein for use in treatment and prevention of autoimmune disorders
03/31/2005US20050070607 Prevent liver damage; respiratory system disorders; cardiovascular disorders; endocrine disorders; infections; monitoring concentration of glutathion in blood
03/31/2005US20050070016 Which mimic activation domains; fusion proteins; binding proteins
03/31/2005US20050070005 High throughput or capillary-based screening for a bioactivity or biomolecule
03/31/2005US20050069929 Methods and compositions for seamless cloning of nucleic acid molecules
03/31/2005US20050069921 Compositions, kits, and methods for stimulation of homologous recombination
03/31/2005US20050069176 General method of classifying plant embryos using a generalized Lorenz-Bayes classifier
03/31/2005CA2539670A1 Nanoliter-scale synthesis of arrayed biomaterials and screening thereof
03/31/2005CA2539325A1 Consensus/ancestral immunogens
03/31/2005CA2537742A1 Immunogenic compositions for streptococcus agalactiae
03/31/2005CA2537462A1 Cell culture media comprising fructose as the primary energy source
03/30/2005EP1517995A2 Compositions and methods for the detection of human t cell receptor variable family gene expression
03/30/2005EP1517710A1 Pegylated factor vii glycoforms
03/30/2005CA2480931A1 General method of classifying plant embryos using a generalized lorenz-bayes classifier
03/24/2005WO2005026329A2 Methods for identifying target nucleic acid molecules
03/24/2005WO2005026328A2 Cpt resistant cell line
03/24/2005WO2005026327A2 Biosynthetic gene cluster for leptomycins
03/24/2005WO2005026324A2 Method and composition for enhancing in vitro embryo development by supplementing culture medium with prostaglandin or a prostaglandin analog
03/24/2005WO2005026323A2 Stationary phases and a purification process using the stationary phases
03/24/2005WO2005026321A2 Protein o-sulfonation
03/24/2005WO2005026319A2 Erythrocytic cells and method for loading solutes
03/24/2005WO2005026318A2 Methods and compositions for producing antigenic responses
03/24/2005WO2005026316A2 Alphavirus vaccines
03/24/2005WO2005026315A2 Method for producing insulin from a natural source and insulin
03/24/2005WO2005026314A2 Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same
03/24/2005WO2005012493A3 Anti-cd19 antibodies
03/24/2005WO2005007824A3 Mutants of vaccinia virus as oncolytic agents
03/24/2005WO2005005604A3 Engineered anti-target immunoglobulin derived proteins, compositions, methods and uses
03/24/2005WO2005003297A3 Mptens as modifiers of the pten/igf pathway and methods of use
03/24/2005WO2005001026A3 Adks as modifiers of the pten pathway and methods of use
03/24/2005WO2004111194A3 Method to increase protein production in culture
03/24/2005WO2004111193A3 Prodrugs of mitotic kinesin inhibitors
03/24/2005WO2004108893A3 Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
03/24/2005WO2004101766A3 Grp94-based compositions and methods of use thereof
03/24/2005WO2004099384A3 Solid phase cell lysis and capture platform
03/24/2005WO2004096986A3 Method for quantitative detection of nucleic acid molecules
03/24/2005WO2004094673A3 Methods for monitoring drug activities in vivo
03/24/2005WO2004083385A3 Quorum sensing signaling in bacteria
03/24/2005WO2004081171A3 Variants of enzymes of the alpha-amylase family
03/24/2005WO2004078934A3 Targeting site-2 protease (s2p) for the treatment of pancreatic cancer
03/24/2005WO2004076650A3 Angiopoietin and fragments, mutants, and analogs thereof and uses of the same
03/24/2005WO2004076647A3 Use of steady-state oxygen gradients to modulate animal cell functions
03/24/2005WO2004076644A3 A composition for delivering an agent to a target cell and uses thereof
03/24/2005WO2004072262A3 Cultured cd14+ antigen presenting cells
03/24/2005WO2004048546A3 Methods for identifying risk of breast cancer and treatments thereof
03/24/2005WO2004044138A3 Chimeric oligomeric compounds and their use in gene modulation
03/24/2005WO2004044134A3 Phosphorous-linked oligomeric compounds and their use in gene modulation
03/24/2005US20050064598 Microfluidic differential extraction cartridge
03/24/2005US20050064462 Methods, compositions, and kits for predicting the effect of compounds on hot flash symptoms
03/24/2005US20050064450 Using unique sequences, polymerase chain reaction and alcohol extraction to generate repetitive sequence removed probes (RSRP) for use in cancer detection
03/24/2005US20050064442 Using allelic variation in breast cancer genes (BRAC1/2) as diagnostic tools in diagnosing/prognosing mammary gland cell proliferative disorders
03/24/2005US20050064440 Using single nucleotide polymorphism in contactin-2 (CNTN-2) and kinesin-7 (CENP-E) genes as diagnostic indicators of cell proliferative disorders; antitumor agents; ribozymes and tumor treatment; RNA interference
03/24/2005US20050064425 Using overlapping and non-overlapping gene expression profiles as tool in detecting transcriptional units of novel function
03/24/2005US20050064420 Expression vector comprising nucleotide sequences coding estrogen response element for use as regulatory tool in heterologous gene expression
03/24/2005US20050063982 GRP94-based compositions and methods of use thereof
03/24/2005US20050063939 Novel biodegradable elastomeric scaffold for tissue engineering and light scattering fingerprinting methods for testing the same
03/24/2005CA2539380A1 Method for producing insulin from a natural source and insulin
03/24/2005CA2537574A1 Stationary phases and a purification process using the stationary phases
03/24/2005CA2533926A1 Methods and compositions for producing antigenic responses
03/23/2005WO2005030935A2 Adjuvant activities of mutants of lt-iia and lt-iib enterotoxin lacking binding to ganglioside
03/23/2005EP1515683A2 Composition containing at least one silicone-polyamide structured oil and a gelling agent, and methods of the use thereof
03/23/2005CN1597950A Icam-4 materials and methods
03/22/2005US6870047 Magnetic pigment
03/17/2005WO2005023996A2 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-β PROTEINS (TGF-βs) IN CELLS
03/17/2005WO2005023994A2 Modified oligonucleotides for telomerase inhibition
03/17/2005WO2005023993A2 Methods and compositions for generation of germline human antibody genes
03/17/2005WO2005023992A2 Compositions and methods for inhibiting white spot syndrome virus (wssv) infection
03/17/2005WO2005023991A2 Small hairpin rna libraries
03/17/2005WO2005023990A2 Trans-splicing mediated photodynamic therapy
03/17/2005WO2005023988A2 Modulation of cell intrinsic strain to control matrix synthesis, secretion, organization and remodeling
03/17/2005WO2005023987A2 Cell-based assays for determining drug action
03/17/2005WO2005023986A2 Microrna as ligands and target molecules
03/17/2005WO2005023985A2 Cytidine deaminase activators, deoxycytidine deaminase activators, vif antagonists, and methods of screening for molecules thereof
03/17/2005WO2005023983A2 Genes having lineage specific variations in copy number and methods of identifying same
03/17/2005WO2005023981A2 Libraries of chimeric cellulose binding proteins and methods of use thereof
03/17/2005WO2005023980A2 Use of complement protein c3 and its derivatives in enhancing mammalian embryo development
03/17/2005WO2005023979A2 Isolated s. mansoni nucleic acid molecules and uses thereof
03/17/2005WO2005003310A3 Glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate mutase promoters for gene expression in oleaginous yeast
03/17/2005WO2004106488A3 Gene expression suppression agents
03/17/2005WO2004094589A3 Secreted proteins
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 100